✦ LIBER ✦

Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections

✍ Scribed by Srikanth Venkatraman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Boceprevir: A Novel NS3/4 Protease Inhib

✍ Olga M. Klibanov; Stephen B. Vickery; Jacqueline L. Olin; Lisa S. Smith; Shannon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Telaprevir: An NS3/4A Protease Inhibitor

✍ Smith, L. S.; Nelson, M.; Naik, S.; Woten, J. 📂 Article 📅 2011 🏛 Harvey Whitney Books Company 🌐 English ⚖ 204 KB

Boceprevir: A Protease Inhibitor for the

✍ Chang, Mei H.; Gordon, Lori A.; Fung, Horatio B. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Discovery and development of telaprevir:

✍ Kwong, Ann D; Kauffman, Robert S; Hurter, Patricia; Mueller, Peter 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 878 KB

Bismacrocyclic Inhibitors of Hepatitis C

✍ John A. McCauley; Michael T. Rudd; Kevin T. Nguyen; Charles J. McIntyre; Joseph 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 2 views

Bismacrocyclic Inhibitors of Hepatitis C

✍ John A. McCauley; Michael T. Rudd; Kevin T. Nguyen; Charles J. McIntyre; Joseph 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 2 views